Search Results for "Takeda"

18:56 EDT 30th October 2014 | BioPortfolio

Original Source: Takeda Global Research & Development Center, Inc.

Takeda Global Research & Development Center, Inc. (TGRD) is a company focused on becoming an integrated, global, world-class pharmaceutical development organization with the ability to rapidly bring superior products to market to improve patient health and enhance the practice of medicine. Established in January 2004, TGRD integrates the clinical development activity of the Takeda Pharmaceutical North America, Inc. (TPNA) R&D group and Takeda's European R&D operation, Takeda Europe Research & Development Ce...

Matching Channels

Pertussis Vaccine acellular Takeda

Actos

Actos, produced by Takeda Pharmaceuticals North America, Inc netted $2.5m in sales in 2009, the 9th highest in the world. Actos is a type of thiazolidinediones, acting to increase sensitivity to I...

Prevacid

Prevacid, produced by Takeda Pharmaceuticals North America, Inc netted $2.5 in sales in 2009, the 10th highest in the world. Prevacid, the trade name for lansoprazole, is a proton pump inhibitor d...

The Top 100 Drugs

The pharmaceutical industry is massive, both in range of products and in financial values. These are the top 200 drugs (ranked in descending order according to total sales in 20010, $), and the co...

Matching News

Jury Finds for Takeda in Diabetes Drug Case Takeda Emphasizes Continued Commitment to Actos and Patient Safety

Deerfield, Ill., May 15, 2014, and Osaka, Japan, May 16, 2014 – Takeda Pharmaceutical Company Limited (“Takeda”) and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc. ...

Table: Takeda comps

Streamlining Takeda's Profit Story Takeda comps Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) has reported steady cost increases on an absolute basis and as a percentage of revenues since FY04, just bef...

UPDATE 1-Takeda, Lilly lose bid to overturn $9 bln award for hiding cancer risk

* Takeda shares muted, up 0.4 pct (Adds Takeda comment, Actos study result, share price, other details)

Takeda Responds to Ruling in Diabetes Drug Case Expresses Continued Confidence in ACTOS

Deerfield, Ill., October 27, 2014, and Osaka, Japan, October 28, 2014–Takeda Pharmaceutical Company Limited (“Takeda”) and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A.,...

Jury finds in favor of Takeda in diabetes drug Actos case

The US subsidiary of Japan’s largest drugmaker, Takeda Pharmaceuticals, yesterday announced that in the case of Bertha Triana and Delores Cipriano v Takeda, et al, No. A680556 the jury found in favo...

Figure: Takeda chronicles

Streamlining Takeda's Profit Story Takeda chronicles Shares of Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) have fallen 45% from a peak of ¥8,400 in February 2007 to ¥4,587 last Friday. The decline s...

Takeda ends Affymax deal, to pull Omontys NDA

Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) is ending a 2006 deal with Affymax Inc. (OTCQB:AFFY) to co-develop and co-commercialize Omontys peginesatide, effective Sept. 10. The pharma said it also wi...

Takeda Announces Reorganization to Propel Continued Growth

Osaka, Japan, September, 16th, 2014 – Takeda Pharmaceutical Company Limited (“Takeda”) today announced plans to redesign its global organizational structure to realize its goal of be...

Matching PubMed Articles

Laparoscopic Removal of a Congenital Seminal Vesicle Cyst in Zinner's Syndrome.

Seminal vesicle cysts are rarely diagnosed, but symptomatic congenital seminal vesicle cysts are reported in the literature describing Zinner syndrome. Case Description: We present the case of a 26-ye...

In Vitro Comparison of Two Widely Used Surgical Sealants for Treating Alveolar Air Leak.

Background Controversies surrounding the efficacy of sealants against alveolar air leak (AAL) are abundant in the literature. We sought to test the widely used sealants, TachoSil (Takeda Pharmaceuti...

Vortioxetine for the treatment of major depression.

Vortioxetine (Lu-AA-21004; 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine hydrobromide) is a novel orally active molecule that is being investigated by Lundbeck and Takeda for the treatment of maj...

World Antibody-Drug Conjugate Summit, October 15-16, 2013, San Francisco, CA.

The World Antibody-Drug Conjugate (WADC) Summits organized by Hanson Wade are currently the largest meetings fully dedicated to ADCs. The first global ADC Summit was organized in Boston in October 201...

Spergularia marina Induces Glucagon-Like Peptide-1 Secretion in NCI-H716 Cells Through Bile Acid Receptor Activation.

Abstract Spergularia marina Griseb. (SM) is a halophyte that grows in mud flats. The aerial portions of SM have been eaten as vegetables and traditionally used to prevent chronic diseases in Korea. Ho...

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement